PL2300043T3 - Efekty przeciwbólowe toksyny peptydowej APETX2 - Google Patents

Efekty przeciwbólowe toksyny peptydowej APETX2

Info

Publication number
PL2300043T3
PL2300043T3 PL09757702T PL09757702T PL2300043T3 PL 2300043 T3 PL2300043 T3 PL 2300043T3 PL 09757702 T PL09757702 T PL 09757702T PL 09757702 T PL09757702 T PL 09757702T PL 2300043 T3 PL2300043 T3 PL 2300043T3
Authority
PL
Poland
Prior art keywords
analgesic effects
peptide toxin
apetx2
toxin apetx2
peptide
Prior art date
Application number
PL09757702T
Other languages
English (en)
Inventor
Emmanuel Deval
Sylvie Diochot
Michel Lazdunski
Eric Lingueglia
Jacques Noel
Original Assignee
Centre Nat Rech Scient
Univ Nice Sophia Antipolis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Nice Sophia Antipolis filed Critical Centre Nat Rech Scient
Publication of PL2300043T3 publication Critical patent/PL2300043T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09757702T 2008-06-06 2009-06-04 Efekty przeciwbólowe toksyny peptydowej APETX2 PL2300043T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0803158A FR2932091B1 (fr) 2008-06-06 2008-06-06 Effets analgesiques de la toxine peptidique apetx2
EP09757702A EP2300043B1 (fr) 2008-06-06 2009-06-04 Effets analgesiques de la toxine peptidique apetx2
PCT/FR2009/000657 WO2009147326A1 (fr) 2008-06-06 2009-06-04 Effets analgesiques de la toxine peptidique apetx2

Publications (1)

Publication Number Publication Date
PL2300043T3 true PL2300043T3 (pl) 2013-03-29

Family

ID=40193730

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09757702T PL2300043T3 (pl) 2008-06-06 2009-06-04 Efekty przeciwbólowe toksyny peptydowej APETX2

Country Status (10)

Country Link
US (1) US8357659B2 (pl)
EP (1) EP2300043B1 (pl)
JP (1) JP5746616B2 (pl)
CA (1) CA2725628A1 (pl)
DK (1) DK2300043T3 (pl)
ES (1) ES2400114T3 (pl)
FR (1) FR2932091B1 (pl)
PL (1) PL2300043T3 (pl)
PT (1) PT2300043E (pl)
WO (1) WO2009147326A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2809681T (lt) 2012-01-31 2019-02-11 Regeneron Pharmaceuticals, Inc. Antikūnai prieš asic1 ir jų panaudojimas
US9371383B2 (en) 2012-01-31 2016-06-21 Regeneron Pharmaceuticals, Inc. Anti-ASIC1 antibodies and uses thereof
CN105233286B (zh) * 2015-09-10 2018-10-30 上海交通大学医学院 含酸敏感离子通道调控剂的制剂及其在治疗瘙痒中的用途
RU2755206C1 (ru) * 2020-05-20 2021-09-14 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство пролонгированного анальгетического действия и лекарственный препарат на его основе
CN113683671B (zh) * 2021-05-31 2023-08-25 海南医学院 一种紫点海葵多肽毒素的制备方法及其抗肿瘤应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7598039B2 (en) * 2007-01-30 2009-10-06 Academia Sinica Treatment of insulin resistance

Also Published As

Publication number Publication date
EP2300043B1 (fr) 2012-10-17
WO2009147326A1 (fr) 2009-12-10
WO2009147326A8 (fr) 2010-12-09
JP5746616B2 (ja) 2015-07-08
JP2011522012A (ja) 2011-07-28
US8357659B2 (en) 2013-01-22
FR2932091B1 (fr) 2012-12-28
ES2400114T3 (es) 2013-04-05
CA2725628A1 (fr) 2009-12-10
EP2300043A1 (fr) 2011-03-30
DK2300043T3 (da) 2013-02-04
FR2932091A1 (fr) 2009-12-11
US20110152197A1 (en) 2011-06-23
PT2300043E (pt) 2013-01-25

Similar Documents

Publication Publication Date Title
IL213341A0 (en) Dipeptide linked medicinal agents
EP2331561A4 (en) PEPTIDE CONJUGATE LIBRARIES AND METHODS OF MAKING SAME
EP2373679A4 (en) HEPPIDINE MINI PEPTIDES AND METHODS OF USE
EP2272817A4 (en) INHIBITOR OF PAI-1
EP2318395A4 (en) IPA INHIBITORS
SI2334177T1 (sl) Peptidna toksinska formulacija
EP2300011A4 (en) METHODS AND THERAPEUTIC COMPOUNDS
HRP20171390T1 (hr) Inhibitor tolerancije na analgetike
EP2588127A4 (en) DIPEPTIDE-NETWORKED MEDICAL ACTIVE SUBSTANCES
ZA201008214B (en) 5-lipoxygenase-activating protein inhibitor
ZA201004765B (en) Inhibitors of iap
EP2270141A4 (en) Lacritin PART PEPTIDE
GB2469592B (en) Field effect transistor
PL2300043T3 (pl) Efekty przeciwbólowe toksyny peptydowej APETX2
GB0724953D0 (en) Methods of peptide modification
EP2222328A4 (en) PROCESS FOR THE ADMINISTRATION OF CONJUGATES
HK1156250A1 (en) Unit dosage of apadenoson
ZA201004979B (en) Extracts of sclerocarya birrea
EP2254901A4 (en) THERAPEUTIC PEPTIDES
HK1131039A1 (en) Pharmaceutical use of sophoricoside
ZA201209021B (en) Therapeutic peptide composition and method
IL207009A0 (en) Extracts of sclerocarya birrea
GB0700152D0 (en) Analgesic